Implant for Ocular Hypertension, Glaucoma Gets FDA Green Light
(MedPage Today) -- The FDA approved the travoprost intracameral implant (iDose TR) for treatment of ocular hypertension and glaucoma, device developer Glaukos announced on Thursday.
The implant is designed to provide long-duration treatment for...
Source: MedPage Today Public Health - Category: American Health Source Type: news
More News: American Health | Glaucoma | Hypertension | International Medicine & Public Health | Travatan